Inventor · disambiguated record
Renata Marcella Oballa
Also filed as: OBALLA RENATA · OBALLA RENATA M · OBALLA RENATA MARCELLA
16 granted patents·10 pending applications·77 citations·filing 2001–2024
91Inventor score
Files withOrion Ophthalmology LLC6TEMPEST THERAPEUTICS INC5MERCK FROSST CANADA LTD4ISABEL ELISE2MERCK FROSST CANADA INC2
Top patents by PatentIndex Score
26 records- 0191US11795156B2Bicyclic carboxamides and methods of use thereofTEMPEST THERAPEUTICS INC·Filed 2022·Granted Oct 24, 2023·1 cites·26 claims
- 0288US10968201B2Bicyclic carboxamides and methods of use thereofTEMPEST THERAPEUTICS INC·Filed 2019·Granted Apr 6, 2021·3 cites·17 claims
- 0388US9481677B2Biaryl ether sulfonamides and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2012·Granted Nov 1, 2016·17 cites·17 claims
- 0487US11267803B2Carbocyclic prolinamide derivativesOrion Ophthalmology LLC·Filed 2020·Granted Mar 8, 2022·2 cites·19 claims
- 0587US9630929B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2012·Granted Apr 25, 2017·11 cites·29 claims
- 0685US2025353829A1Bicyclic carboxamides and methods of use thereofTEMPEST THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0784US12215093B2Bicyclic carboxamides and methods of use thereofTEMPEST THERAPEUTICS INC·Filed 2023·Granted Feb 4, 2025·0 cites·18 claims
- 0884US11472789B2Bicyclic carboxamides and methods of use thereofTEMPEST THERAPEUTICS INC·Filed 2020·Granted Oct 18, 2022·1 cites·18 claims
- 0984US10526315B2Carbocyclic prolinamide derivativesOrion Ophthalmology LLC·Filed 2017·Granted Jan 7, 2020·5 cites·12 claims
- 1082US6835727B2Cathepsin cysteine protease inhibitorsMERCK FROSST CANADA INC·Filed 2001·Granted Dec 28, 2004·24 cites·16 claims
- 1174US7928091B2Cathepsin cysteine protease inhibitorsMERCK FROSST CANADA LTD·Filed 2006·Granted Apr 19, 2011·2 cites·9 claims
- 1273US6525036B2Compounds and compositions as protease inhibitorsMERCK & CO INC·Filed 2001·Granted Feb 25, 2003·8 cites·25 claims
- 1372US10730832B2Aliphatic prolinamide derivativesOrion Ophthalmology LLC·Filed 2017·Granted Aug 4, 2020·1 cites·16 claims
- 1471US11377439B2Heterocyclic prolinamide derivativesOrion Ophthalmology LLC·Filed 2017·Granted Jul 5, 2022·1 cites·31 claims
- 1570US7799787B2Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA LTD·Filed 2006·Granted Sep 21, 2010·1 cites·6 claims
- 1668US11866422B2Carbocyclic prolinamide derivativesOrion Ophthalmology LLC·Filed 2021·Granted Jan 9, 2024·0 cites·1 claims
- 1761US2022267306A1Heterocyclic prolinamide derivativesOrion Ophthalmology LLC·Filed 2022·Application pending·0 cites
- 1850US2010063013A1Cathepsin cysteine protease inhibitorsOBALLA RENATA·Filed 2008·Application pending·0 cites
- 1946US2010004245A1Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA LTD·Filed 2007·Application pending·0 cites
- 2045US7405229B2Cathepsin cysteine protease inhibitorsMERCK FROSST CANADA INC·Filed 2004·Granted Jul 29, 2008·0 cites·7 claims
- 2144US2009118296A1Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 DesaturaseMERCK FROSST CANADA LTD·Filed 2006·Application pending·0 cites
- 2243US2009291988A1Reversible Inhibitors of Monoamine Oxidase A and BOBALLA RENATA·Filed 2006·Application pending·0 cites
- 2342US2009264479A1Papain Family Cysteine Protease Inhibitors for the Treatment of Parasitic DiseasesBLACK CAMERON·Filed 2006·Application pending·0 cites
- 2438US2009170828A1Azetidine Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 DesaturaseISABEL ELISE·Filed 2007·Application pending·0 cites
- 2532US2012010186A1Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseLACHANCE NICOLAS·Filed 2010·Application pending·0 cites
- 2627US2011301143A1Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseISABEL ELISE·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →